Pharma and Biotech
Competitors: | Okyo Pharma Limited , Nuformix |
CEO: | Vladislav Sandler Ph.D. |
Non-Executive Chairman: | Marc Feldmann |
Non-Executive Dir: | Alexis M. Sandler, Peter Redmond |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Website: | http://hemogenyx.com/ |
Sector: | Pharma and Biotech(LSE) |
Overseas Listings: | BATSLON:SILFL |
ISIN: | GB00BYX3WZ24 |
Currency | UK Pounds |
Share Price | 1.59p |
Change Today | -0.023p |
% Change | -1.43 % |
52 Week High | 3.96 |
52 Week Low | 1.17 |
Volume | 5,559,012 |
Shares Issued | 1,341.82m |
Market Cap | £21.27m |
RiskGrade | 340 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:08 | 9 @ 1.60p |
16:07 | 491 @ 1.60p |
16:06 | 99,259 @ 1.57p |
16:05 | 100,000 @ 1.57p |
16:04 | 100,000 @ 1.57p |
You are here: research